New Jersey Appellate Panel Reverses Stent Preemption Ruling In Part
TRENTON, N.J. – A New Jersey Superior Court Appellate Division panel on July 23 reversed dismissal of the manufacturing defect, failure to warn and breach of express warranty claims of a group of plaintiffs who claim to have been injured by Johnson & Johnson (J&J) and Cordis Corp.’s Cypher Sirolimus-Eluting Coronary stents, holding that these claims are not preempted by federal law (Vonnie Cornett, et al. v. Johnson & Johnson, et al., No. A-4694-08T1, A-5539-08T1, N.J. Super., App. Div.).
Full story on lexis.com
View full post on LexisNexis® Mealey’s™ Legal News
'preemption', Appellate, Jersey, panel, PART, reverses, Ruling, Stent